Molekularne mechanizmy lekoopornosci pasozytow

• Autorzy: Majewska A C
• Języki publikacji: PL

Abstrakty

EN

In spite of the enormous achievements of medical and biological sciences, parasites still constitute important medical and veterinary problem. One of the main obstacles in the treatment and eradication of human and animals parasitic diseases is drug resistance of parasites. This phenomenon has more and more frequently been described both in medical and veterinary practice. The application of numerous molecular biology techniques in modern parasitological laboratories have enabled the investigations of parasites at the DNA level. The results of these studies have revolutionised our knowledge and made possible the recognition of not only the reasons and extent of genetic differentiation of parasites but also the recognition of genetic and molecular mechamisms of drug resistance. The results of many studies showed interspecific, interpopulational, and even intrapopulational heterogeneity of parasites in their sensitivity to antiparasitic drugs. Moreover, it has been found that in various parasites there often exist different molecular bases of the drug resistance. The review concerns different molecular mechanisms of drug resistance in selected parasite taxa (Schistosoma spp., Haemonchus contortus, Leishmania spp., Plasmodium falciparum, Entamoeba histolytica).

Słowa kluczowe

PL

lekoopornosc; parazytologia; mechanizmy molekularne; pasozyty

• Wydawca: -
• Czasopismo: Wiadomości Parazytologiczne
• Rocznik: 1998
• Tom: 44
• Numer: 2
• Opis fizyczny: s.139-150, bibliogr.

Twórcy

autor

Majewska A C

• Akademia Medyczna, ul.Fredry 10, 61-701 Poznan

Bibliografia

• ASHFORD R. W., DESJEUX P., DE RAADT P. 1992. Estimation of population at risk of infection and number of cases of Leishmaniasis. Parasitol. Today 8: 104-105.
• AYALA P., SAMUELSON J., WRITH D., OROZCO E. 1990. Entamoeba histolytica: physiology of multidrug resistance. Exp. Parasitol. 71: 169-175.
• BELLO A. R., NARE B., GREEDMAN D., HARDY L., BEVERLEY S. M. 1994. PTR1: A reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major. Proc. Natl Acad. Sci. USA 91: 11442-11446.
• BERMAN J. D., EDWARDS N., KING M., GROGL M. 1989. Biochemistry of Pentostam-resistant Leishmania. Am. J. Trop. Med. Hyg. 40: 159-164.
• BEVERLEY S. M., CODERRE J. A., SANTI D. V., SCHINKE R. T. 1984. Unstable amplifications in methotrexate-resistant Leishmania consist of extrachromosomal circles which relocalize during stabilization. Cell. 38: 431-439.
• CALLAHAN H. L., BEVERLEY S. M. 1991. Heavy metal resistance: a new role for P-glycoprotein in Leishmania. J. Biol. Chem. 266: 18427-18430.
• - - 1992. A member of the aldoketo reductase family confers methotrexate resistance in Leishmania. Ibid. 267: 24165-24168.
• CHOW L. M. C., WONG A. K. C., ULLMAN B., WIRTH D. F. 1993. Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii. Mol. Biochem. Parasitol. 60: 195-208.
• CIOLI D., PICA-MATTOCCIA L. 1984. Genetic analysis of hycanthone resistance in Schistosoma mansoni. Am. J. Trop. Med. Hyg. 33: 80-88.
• - - ARCHER S. 1993. Drug resistance in Schistosomes. Parasitol. Today 9: 162-166.
• - - MORONI R. 1992. Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene. Exp. Parasitol. 75: 425-432.
• COLE S. P. C., BHARDWAJ G., GERLACH J. H., MACKIE J. E., GRANT C. E., ALMQUIST K. C., STEWART A. J., KURZ E. U., DUNCAN A. M. V., DEELEY R. G. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654.
• COLES G. C., BRUCE J. I., KINOTI G. K., MUTAHI W. T., DIAS E. P., KATZ N. 1986. Drug resistance in schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 80: 347.
• - MUTAHI W. T., KINOTI G. K., BRUCE J. I., KATZ N. 1987. Tolerance of Kenyan Schistosoma mansoni to oxamniquine. Ibid. 81: 782-785.
• COWMAN A. F., GALATIS D., THOMPSON J. K. 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl Acad. Sci. USA 91: 1143-1147.
• - KARCZ S., GALATIS D., CULVENOR J. G. 1991. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 113: 1033-1042.
• DAVIS A. 1982. Management of the patient with schistosomiasis. In: Jordan P., Webbe G. [eds], Schistosomiasis, Epidemiology, Treatment and Control. Heinemann: 184-226.
• DAY T. A., BENNETT J. L., PAX R. A. 1992. Praziquantel: the enigmatic antiparasitic. Parasitol. Today 8: 342-344.
• DESCOTEAUX S., AYALA P., OROZCO E., SAMUELSON J. 1992. Primary sequence of two P-glycoprotein genes of Entamoeba histolytica. Mol. Biochem. Parasitol. 54: 201-212.
• DETKE S., KATAKURA K., CHANG K. P. 1989. DNA amplification in arsenite-resistant Leishmania. Exp. Cell Res. 180: 161-170.
• DRAPER C. C., HILLS M., KILIMALI V. A., BRUBAKER G. 1988. Serial studies on the evolution of drug resistance in malaria in an area of East Africa: findings from 1979 up to 1986. J. Trop. Med. Hyg. 91: 265-273.
• DRISCOLL M., DEAN E., REILLY E., BERGHOLZ E., CHALFIE M. 1989. Genetic and molecular analysis of a Caenorhabditis elegans β-tubulin that conveys benzimidazole sensitivity. J. Cell. Biol. 109: 2993-3003.
• ELLENBERGER T. E., BEVERLEY S. M. 1989. Multiple drug resistance and conservative amplification of the H region in Leishmania major. J. Biol. Chem. 264: 15094-15103.
• FALLON P. G., DOENHOFF M. J. 1994. Drug-resistance schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specilic. Am. J. Trop. Med. Hyg. 51: 83-88.
• FOOTE S. J., THOMPSON J. K., COWMAN A. F., KEMP D. J. 1989. Amplification of the multidrug-resistance gene is some chloroquine-resistant isolates of Plasmodium falciparum. Cell. 57: 921-930.
• GAMARRO F. AMADOR M. V., CHIQUERO M. J., LÉGARÉ D., OUELLETTE M., CASTANYS S. 1994. Multidrug resistance phenotype and P-glycoprotein overexpression in a methotrexate-resistant Leishmania infantum. Biochem. Pharmacol. 47: 1939-1947.
• GAY F., BUSTOS D. G., DIQUET B., RIVERO L. R., LITAUDON M., PIC.HET C., DANIS M., GENTILINI M. 1990. Cross-resistance between mefloquine and halofantrine. Lancet 336: 1262.
• GEARY T. G., NULF S. C., FAVREAU M. A., LIANG TANG, PRlCHARD R. K., HATZENBUHLER N. T., SHEA M. H., ALEXANDER S. J., KLEIN R. D. 1992. Three β-tubulin cDNAs from the parasitic nematode Haemonchus contortus. Mol. Biochem. Parasitol. 50: 295-306.
• GOTTESMAN M. M., PASTAN I. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427.
• GRANT W. N. 1992. Transformation of Caenorhabditis elegans with genes from parasitic nematodes. Parasitol. Today 8: 344-346.
• GROGL M., THOMASON T. N., FRANKE E. D. 1992. Characteristic of multidrug resistance in Plasmodium and Leishmania: detection of P-glycoprotein-like components. Am. J. Trop. Med. Hyg. 47: 117-126.
• HENDERSON D. M., SIFRI C. D., RODGERS M., WRITH D. F., HENDRICKSON N., ULLMAN B. 1992. Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdrl gene. Mol. Cell. Biol. 12: 2855-2865.
• ISMAIL M., ATTIA M., METWEALLY A. A., FARGHALY A. M., BRUCE J., BENNETT J., EL-BADAWY A. A., HUSSEIN M. H. 1994a. Assessment or praziquantel therapy in treatment of Schistosoma mansoni infection. J. Egypt. Soc. Parasitol. 24: 231-238.
• - TAHA S. A., FARGHALY A. M., EL-AZONY A. S. 1994b. Laboratory induced resistance to praziquantel in experimental schistosomiasis. Ibid. 24: 685-695.
• JACKSON J. E., TALLY J. D., ELLIS W. Y., MEBRAHTU Y. B., LAWYER P. G., WERE J. B., REED S. G., PANISKO D. M., LIMMER B. L. 1990. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania spp. from patients unresponsive to pentavalent antimony therapy. Am. J. Trop. Med. Hyg. 43: 464-480.
• KATAKURA K., CHANG K. P. 1989. H DNA amplification in Leishmania resistant to both arsenite and methotrexate. Mol. Biochem. Parasitol. 34: 189-192.
• KATZ N., DIAS E. P., ARAUJO N., DE SOUZA C. P. 1973. Estudo de urna cepa humana do Schistosoma mansoni resistente a agentes esquissomicides. Rev. Soc. Brasil. Med. Trop. 7: 381-387.
• KROGSTAD D. J., GLUZMAN I. Y., KYLE D. E., ODUOLA A. M. J., MARTIN S. K., MILHOUS W. K., SCHLESINGER P. H. 1987. Effiux of chloroquine resistance in Plasmodium falciparum: mechanism of chloroquine resistance: Science 238: 1283-1285.
• KWA M. S. G., VEENSTRA J. G., Roos M. H. 1993. Molecular characterization of β-tubulin genes present in benzimidazole-resistant populations of Haemonchus contortus. Mol. Biochem. Parasitol. 60: 133-144.
• - - - 1994. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in β-tubulin isotype 1. Ibid. 63: 299-303.
• MARTIN S. K., ODUOLA A. M. J., MILHOUS W. K. 1987. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 235: 899-901.
• OUELLETTE M., PAPADOPOULOU B. 1993. Mechanisms of drug resistance in Leishmania. Parasitol. Today 9: 150-153.
• - FASE-FOWLER F., BORST P. 1990. The amplified H-circle of methotrexate-resistance Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J. 9: 1027-1033.
• - HETTEMA E., WUST D., FASE-FOWLER F., BORST P. 1991. Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania. Ibid. 10: 1009-1016.
• PAPADOPOULOU B., ROY G., OUELLETTE M. 1991. A novel antifolate resistance gene on the amplified H circle of Leishmania. Ibid. 11: 3601-3608.
• - - DEY S., ROSEN B. P., OUELLETTE M. 1994. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance. J. Biol. Chem. 269: 11980-11986.
• PICA-MATTOCCIA L., ARCHER S., CIOLI D. 1982. Hycanthone resistance in schistosomes correlates with lacked an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules. Mol. Biochem. Parasitol. 55: 167-176.
• ROOS M. H., BOERSEMA J. H., BORGSTEEDE F. H. M., CORNELISSEN J., TAYLOR M., RUITENBERG E. J. 1990. Molecular analysis of selection for benzimidazole resistance in the sheep parasite Haemonchus contortus. Ibid. 43: 77-88.
• - KWA M. S. G., GRANT W. N. 1995. New genetic and practical implications of selection for anthelmintic resistance in parasitic nematodes. Parasitol. Today 11: 148-150.
• SAMUELSON J., AYALA P., OROZCO E., WRITH D. 1990. Emetine-resistant mutants of Entamoeba hivtolytica overexpress mRNAs for multidrug resistance. Mol. Biochem. Parasitol. 38: 281-290.
• STELMA F. F., TALLA I., STURROCK R. F., NIANG M., GRYSEELS B. 1992. Epidemiology and chemotherapy of Schistosoma mansoni infection in a recently exposed community in northem Senegal. Abstracts of VIth European Multicolloquium of Parasitology, September 7 -11, 1992, The Hague, The Netherlands: 54.
• ULLMAN B. 1995. Multidrug resistance and P-glycoproteins in parasitic Protozoa. J. Bioenerg. Biomembr. 27: 77-84.
• WILSON C. M., VOLKMAN S. K., THAITHONG S., MARTIN R. K., KYLE D. E., MILHOUS W. K., WIRTH D. F. 1993. Amplification of pfmdrl associated with mefloquine and halofantrine in Plasmodium falciparum. Mol. Biochem. Parasitol. 57: 151-160.
• WHO Technical Report Series. 1985. The control of schistosomiasis. No. 728: 1-114.
• - Weekly Epidemiological Records. 1993. World malaria situation in 1991. Part I and Part II. 68: 245-260.
• - 1997. Amoebiasis. 72: 97-100.
• ZALIS M. G., WILSON C. M., ZHANG Y., WIRTH D. F. 1993. Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol. Biochem. Parasitol. 62: 83-92.
• ZHANG W. W., SAMUELSON J. 1993. Molecular cloning of the gene for a novel ABC superfamily transporter of Entamoeba histolytica. Ibid. 62: 131-134.